Dova is…

…a clinical-stage pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is a high unmet medical need. With a nimble approach and a team of bright minds aglow with passion, we’re dedicated to bringing brilliant medicine to market.

Brilliant Solution: Avatrombopag

After meeting the primary and secondary endpoints in our two pivotal Phase III clinical trials, an NDA is planned for submission to the U.S. Food & Drug Administration in Q3 of 2017.

Learn More

Bright Minds: We’re Bringing Passion to Pharmaceuticals

The Dova leaders are outsmarting traditional ways of thinking and breaking new ground every day.

Meet the Team